HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), announced it has appointed Robert Spitale, Ph.D., Associate Director and Associate Dean of Research in the School of Pharmacy and Pharmaceutical Services at the University of California, Irvine (UC Irvine), to the HTG Therapeutics Scientific Advisory Board.
February 3, 2022
· 4 min read